Viewing StudyNCT02098395



Ignite Creation Date: 2024-05-06 @ 2:39 AM
Last Modification Date: 2024-10-26 @ 11:21 AM
Study NCT ID: NCT02098395
Status: COMPLETED
Last Update Posted: 2017-02-09
First Post: 2014-03-25

Brief Title: The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
Sponsor: Novo Nordisk AS
Organization: Novo Nordisk AS

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-05
Start Date Type: None
Primary Completion Date: 2015-04
Primary Completion Date Type: ACTUAL
Completion Date: 2015-04
Completion Date Type: ACTUAL
First Submit Date: 2014-03-25
First Submit QC Date: March 25 2014
Study First Post Date: 2014-03-28
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2016-06-03
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-12-15
Last Update Post Date: 2017-02-09
Last Update Post Date Type: ESTIMATED